Innovative Collaboration Aims to Enhance Metastatic Colorectal Cancer Treatment Using LifeTracDx® Blood Test Creatv Bio partners with CytoDyn to utilize LifeTracDx® blood test for exploratory biomarker analysis in clinical trials for colorectal cancer treatment.

Innovative Collaboration Aims to Enhance Metastatic Colorectal Cancer Treatment Using LifeTracDx® Blood Test #USA #Creatv_Bio #Monmouth_Junction #CytoDyn #LifeTracDx

Innovative Blood Test Offers Hope for Treating Metastatic Triple-Negative Breast Cancer Creatv Bio's LifeTracDx blood test shows promise in monitoring PD-L1 upregulation for metastatic triple-negative breast cancer treatment options, improving survival rates.

Innovative Blood Test Offers Hope for Treating Metastatic Triple-Negative Breast Cancer #USA #Creatv_Bio #Monmouth_Junction #LifeTracDx #mTNBC

Cha-Mei Tang Recognized for Excellence in Pioneering Cancer Diagnostics Dr. Cha-Mei Tang has been acknowledged as a Pinnacle Professional Member for her groundbreaking work in cancer diagnostics and screening technology.

Cha-Mei Tang Recognized for Excellence in Pioneering Cancer Diagnostics #United_States #Cancer_Diagnostics #Potomac #Creatv_Bio #Cha-Mei_Tang

Blood Test for PD-L1 Uncovers Crucial Insights in Metastatic Breast Cancer Treatments Innovative research showcases how PD-L1 expression measured by blood tests provides vital clinical data for patients with metastatic breast cancer receiving novel therapies.

Blood Test for PD-L1 Uncovers Crucial Insights in Metastatic Breast Cancer Treatments #United_States #Creatv_Bio #PD-L1_Test #Metastatic_Breast_Cancer #Monmouth_Junction